![]() ROCAtest ROCAtest (also known as Abcodia) is an innovative biotech company engaged in the validation and discovery of molecular biomarkers. | |||
Founding Date | Founding Date 2012 | Founding Date 2010 | Founding Date 2007 |
Type | Type Private | Type Private | Type Public |
Tags | |||
Locations | Locations Sandwich, GB HQ | Locations Leeds, GB HQ Royston, GB Boston, US Memphis, US | Locations Cambridge, US HQ |
Employees | Employees N/A | Employees 29 | Employees 324187% increase |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) £568.3k (FY, 2015) | Revenue (est.) $236.2m (FY, 2025) |
Cost of goods | Cost of goods £3.3m (FY, 2015) | Cost of goods £28.5k (FY, 2015) | Cost of goods $39.5m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit £539.7k (FY, 2015) | Gross profit $196.7m (FY, 2025) |
Net income | Net income (£3.7m) (FY, 2015) | Net income (£2.7m) (FY, 2015) | Net income ($5.3m) (FY, 2025) |
Funding | |||
Latest funding round | Latest funding round $ 3.9m (over 11 years ago) | Latest funding round $ 8.3m (about 11 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 16.1m | Total funding raised $ 17m | Total funding raised N/A |

ROCAtest (also known as Abcodia) is an innovative biotech company engaged in the validation and discovery of molecular biomarkers.
View company
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
View company